Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Oriole Resources, Solvonis Therapeutics, Pantheon International, Tissue Regenix - Small Cap Snapshot

Oriole Resources, Solvonis Therapeutics, Pantheon International, Tissue Regenix - Small Cap Snapshot

Oriole Resources PLC (AIM:ORR) kicked off 2026 with strong gold hits from the MB01-N target at its Mbe project in Cameroon. Early drilling delivered wide intersections, including high-grade veins, with the programme nearly halfway complete. Read more

Solvonis Therapeutics PLC (LSE:SVNS) has secured new US patent protection for its PTSD drug discovery programme. The company expects to pick a lead compound in early 2026, boosting confidence in its science and commercial potential. Read more

Pantheon International PLC (LSE:PIN) reported a November NAV of 520.8p, up slightly month on month. The firm continued heavy share buybacks and ended November with solid cash, distributions and private equity valuations. Read more

Tissue Regenix Group PLC (AIM:TRX) shares have now left AIM and moved to a private secondary market. Trading will take place via Asset Match, using periodic auctions instead of daily market dealing. Read more

Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.